Published in J Natl Cancer Inst on March 06, 1996
Psoriasin (S100A7) expression and invasive breast cancer. Am J Pathol (1999) 1.56
ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR. Breast Cancer Res (2012) 0.99
Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis. BMC Cancer (2005) 0.92
POU transcription factors Brn-3a and Brn-3b interact with the estrogen receptor and differentially regulate transcriptional activity via an estrogen response element. Mol Cell Biol (1998) 0.90
Expression of estrogen receptor variant messenger RNAs and determination of estrogen receptor status in human breast cancer. Am J Pathol (1997) 0.85
Sex steroid hormones, bone mineral density, and risk of breast cancer. Environ Health Perspect (1997) 0.81
Analysis of estrogen receptor isoforms and variants in breast cancer cell lines. Exp Ther Med (2011) 0.81
Altered expression of estrogen receptor-alpha variant messenger RNAs between adjacent normal breast and breast tumor tissues. Breast Cancer Res (2000) 0.80
Altered expression of exon 6 deleted progesterone receptor variant mRNA between normal human breast and breast tumour tissues. Br J Cancer (1999) 0.78
Oestrogen receptor-alpha variant mRNA expression in primary human breast tumours and matched lymph node metastases. Br J Cancer (1999) 0.78
Classification of breast cancer cells on the basis of a functional assay for estrogen receptor. Mol Med (1998) 0.78
Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growth. Sci Rep (2016) 0.75
Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res (2000) 5.74
Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol (2001) 2.71
The steroid receptor RNA activator is the first functional RNA encoding a protein. FEBS Lett (2004) 1.92
Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast. Am J Pathol (2001) 1.71
Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma: clues to tumour-microenvironment interactions. Hum Mol Genet (2001) 1.66
Eosinophilic fasciitis in a pair of siblings. Arthritis Rheum (1989) 1.66
Psoriasin (S100A7) expression and invasive breast cancer. Am J Pathol (1999) 1.56
Altered estrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesis. Cancer Res (1998) 1.46
Pro-protein convertase gene expression in human breast cancer. Int J Cancer (1997) 1.43
Altered expression of estrogen receptor coregulators during human breast tumorigenesis. Cancer Res (2000) 1.42
The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression. Clin Cancer Res (1998) 1.41
Microdissection RT-PCR analysis of gene expression in pathologically defined frozen tissue sections. Biotechniques (1996) 1.39
Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen. Cancer Res (1985) 1.37
The human orphan receptor PXR messenger RNA is expressed in both normal and neoplastic breast tissue. Clin Cancer Res (1999) 1.37
Level of ubiquitinated histone H2B in chromatin is coupled to ongoing transcription. Biochemistry (1990) 1.37
Estrogen induces insulin-like growth factor-I expression in the rat uterus. Mol Endocrinol (1987) 1.36
Beware of connective tissue proteins: assignment and implications of collagen absorptions in infrared spectra of human tissues. Biochim Biophys Acta (1995) 1.34
Expression of estrogen receptor-beta in human breast tumors. J Clin Endocrinol Metab (1997) 1.34
Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. Cancer Res (2001) 1.34
Estrogen receptor-beta messenger RNA expression in human breast tumor biopsies: relationship to steroid receptor status and regulation by progestins. Cancer Res (1999) 1.34
Expression of lumican in human breast carcinoma. Cancer Res (1998) 1.33
Tumour-infiltrating FOXP3(+) lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer. Br J Cancer (2012) 1.33
Expression of the steroid receptor RNA activator in human breast tumors. Cancer Res (1999) 1.32
Differential expression of psoriasin messenger RNA between in situ and invasive human breast carcinoma. Cancer Res (1996) 1.31
Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours. Br J Cancer (2006) 1.29
High-affinity anti-oestrogen binding site distinct from the oestrogen receptor. Nature (1980) 1.29
International variation in the management of infants hospitalized with respiratory syncytial virus. International RSV Study Group. Eur J Pediatr (1998) 1.24
Expression of estrogen receptor beta1, beta2, and beta5 messenger RNAs in human breast tissue. Cancer Res (1999) 1.23
Lumican and decorin are differentially expressed in human breast carcinoma. J Pathol (2000) 1.21
Psoriasin (S100A7). Int J Biochem Cell Biol (1998) 1.20
Characterization of estrogen receptor variant mRNAs from human breast cancers. Mol Endocrinol (1992) 1.18
Putative functional characteristics of human estrogen receptor-beta isoforms. J Mol Endocrinol (2003) 1.17
The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer. Br J Cancer (2002) 1.16
A new human breast carcinoma cell line (PMC42) with stem cell characteristics. III. Hormone receptor status and responsiveness. J Natl Cancer Inst (1984) 1.14
Regulation of growth and tumorigenicity of breast cancer cells by the low molecular weight GTPase Rad and nm23. Cancer Res (2001) 1.14
S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer. Oncogene (2010) 1.09
Reciprocal negative regulation between S100A7/psoriasin and beta-catenin signaling plays an important role in tumor progression of squamous cell carcinoma of oral cavity. Oncogene (2008) 1.05
A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis. J Clin Endocrinol Metab (1997) 1.04
Inhibition of transcription selectively reduces the level of ubiquitinated histone H2B in chromatin. Biochem Biophys Res Commun (1994) 1.04
Effects of biologically active metabolites of tamoxifen on the proliferation kinetics of MCF-7 human breast cancer cells in vitro. Cancer Res (1983) 1.02
Estrogen receptor-beta mRNA variants in human and murine tissues. Mol Cell Endocrinol (1998) 1.02
Relationship of coregulator and oestrogen receptor isoform expression to de novo tamoxifen resistance in human breast cancer. Br J Cancer (2002) 1.00
Mechanisms of oestrogen antagonism by nonsteroidal antioestrogens. Mol Cell Endocrinol (1982) 0.99
Evidence for a ras gene mutation in azoxymethane-induced colonic aberrant crypts in Sprague-Dawley rats: earliest recognizable precursor lesions of experimental colon cancer. Carcinogenesis (1992) 0.99
Factors affecting the sensitivity of T-47D human breast cancer cells to tamoxifen. Cancer Res (1984) 0.96
Potential role of estrogen receptor alpha (ERalpha) phosphorylated at Serine118 in human breast cancer in vivo. J Steroid Biochem Mol Biol (2006) 0.96
Microsomal binding sites for nonsteroidal anti-estrogens in MCF 7 human mammary carcinoma cells. Demonstration of high affinity and narrow specificity for basic ether derivatives of triphenylethylene. J Biol Chem (1984) 0.96
Estrogen receptor variants and mutations. J Steroid Biochem Mol Biol (1997) 0.95
Measurement of the relative binding affinity of zearalenone, alpha-zearalenol and beta-zearalenol for uterine and oviduct estrogen receptors in swine, rats and chickens: an indicator of estrogenic potencies. Comp Biochem Physiol C (1989) 0.94
Role of wild-type estrogen receptor-beta in mitochondrial cytoprotection of cultured normal male and female human lens epithelial cells. Am J Physiol Endocrinol Metab (2008) 0.94
Expression of small breast epithelial mucin (SBEM) protein in tissue microarrays (TMAs) of primary invasive breast cancers. Histopathology (2008) 0.93
Mammaglobin, a potential marker of breast cancer nodal metastasis. J Pathol (1999) 0.93
The potential role for prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasis. Br J Cancer (1999) 0.91
Comparison of the biochemical responses to human parathyroid hormone-(1-31)NH2 and hPTH-(1-34) in healthy humans. J Clin Endocrinol Metab (1999) 0.90
Immunohistochemical assay for oestrogen receptors in paraffin wax sections of breast carcinoma using a new monoclonal antibody. J Pathol (1996) 0.90
Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cells. Cancer Res (1986) 0.90
Preimplantation development of in vitro-matured and in vitro-fertilized ovine zygotes: comparison between coculture on oviduct epithelial cell monolayers and culture under low oxygen atmosphere. Biol Reprod (1994) 0.89
c-myc oncogene expression in estrogen-dependent and -independent breast cancer. Clin Chem (1993) 0.88
The binding of tamoxifen to human mammary carcinoma cytosol. Eur J Cancer (1980) 0.88
Oestrogen receptor variants and mutations in human breast cancer. Ann Med (1997) 0.88
Antitumor activity of clomiphene analogs in vitro: relationship to affinity for the estrogen receptor and another high affinity antiestrogen-binding site. J Clin Endocrinol Metab (1983) 0.88
Production of digoxigenin-labelled RNA probes and the detection of cytokine mRNA in rat spleen and brain by in situ hybridization. Brain Res Brain Res Protoc (1998) 0.88
Identification of differentially expressed genes using minute amounts of RNA. Biotechniques (1996) 0.87
Biological actions of prolactin in human breast cancer. Recent Prog Horm Res (1987) 0.87
Identification of a serum-inducible messenger RNA (5B10) as the mouse homologue of calcyclin: tissue distribution and expression in metastatic, ras-transformed NIH 3T3 cells. Cell Growth Differ (1990) 0.87
Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration. Cancer Res (1984) 0.87
Estrogen induction of N-myc and c-myc proto-oncogene expression in the rat uterus. Endocrinology (1987) 0.87
Elevated mitogen-activated protein kinase activity in estrogen-nonresponsive human breast cancer cells. Cancer Res (1998) 0.87
Estrogen regulates the association of intermediate filament proteins with nuclear DNA in human breast cancer cells. J Biol Chem (1998) 0.86
Extracellular calcium-sensing receptor is expressed in rat hepatocytes. coupling to intracellular calcium mobilization and stimulation of bile flow. J Biol Chem (2000) 0.86
A high-affinity binding site for the antioestrogens, tamoxifen and CI 628, in immature rat uterine cytosol which is distinct from the oestrogen receptor. J Endocrinol (1981) 0.85
Expression of estrogen receptor variant messenger RNAs and determination of estrogen receptor status in human breast cancer. Am J Pathol (1997) 0.85
Epidermal growth factor gene expression in human breast cancer biopsy samples: relationship to estrogen and progesterone receptor gene expression. Cancer Res (1990) 0.85
A point mutation in the human estrogen receptor gene is associated with the expression of an abnormal estrogen receptor mRNA containing a 69 novel nucleotide insertion. Breast Cancer Res Treat (1997) 0.85
Expression of a repressor of estrogen receptor activity in human breast tumors: relationship to some known prognostic markers. Cancer Res (2000) 0.85
Differential effects of tamoxifen and analogs with nonbasic side chains on cell proliferation in vitro. Endocrinology (1985) 0.84
Estrogen regulation of nuclear matrix-intermediate filament proteins in human breast cancer cells. J Cell Biochem (1996) 0.84
Analysis of human breast cancer nuclear proteins binding to the promoter elements of the c-myc gene. J Cell Biochem (1996) 0.83
Prevalence of estrogen receptor variant messenger RNAs in human breast cancer. Cancer Res (1996) 0.83
The knee-chest position does not improve the efficacy of ipecac-induced emesis. Am J Emerg Med (1989) 0.83